Suboxone and Clindamycin phosphate drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Suboxone and Clindamycin phosphate together. This review analyzes the effectiveness and drug interactions between Suboxone and Clindamycin phosphate. It is created by eHealthMe based on reports of 18 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Suboxone and Clindamycin phosphate, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Suboxone and Clindamycin phosphate

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. (latest outcomes from Suboxone 15,970 users)

Clindamycin Phosphate

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. (latest outcomes from Clindamycin phosphate 1,647 users)

On Jan, 25, 2017

18 people who take Suboxone, Clindamycin Phosphate are studied.


Number of reports submitted per year:

Suboxone and Clindamycin phosphate drug interactions.

Most common drug interactions over time *:

< 1 month:
  • chest pain
  • drug abuser
  • electrocardiogram qt prolonged
  • electrocardiogram st-t segment abnormal
  • electrocardiogram u-wave abnormality
1 - 6 months:
  • feeding disorder neonatal
  • foetal exposure during pregnancy
  • low birth weight baby
  • premature baby
  • respiratory disorder neonatal
  • breech presentation
6 - 12 months:
  • low birth weight baby
  • premature baby
  • respiratory disorder neonatal
  • attention deficit/hyperactivity disorder
  • breech presentation
  • hepatocellular injury
  • maternal drugs affecting foetus
  • restlessness
  • foetal exposure during pregnancy
  • feeding disorder neonatal
2 - 5 years:
  • anxiety
  • homicidal ideation
  • major depression
  • panic attack
  • post-traumatic stress disorder
  • suicide attempt
5 - 10 years:
  • acute hepatic failure
  • hepatic encephalopathy
not specified:
  • fatigue
  • hypoaesthesia
  • anxiety
  • chest pain
  • abdominal pain
  • animal bite
  • blood cholesterol increased
  • constipation
  • decreased interest
  • excoriation

Most common drug interactions by gender *:

female:
  • rash
  • acute hepatic failure
  • anxiety
  • hepatic encephalopathy
  • homicidal ideation
  • major depression
  • panic attack
  • post-traumatic stress disorder
  • suicide attempt
male:
  • fatigue
  • hypoaesthesia
  • chest pain
  • abdominal pain
  • animal bite
  • anxiety
  • blood cholesterol increased
  • constipation
  • decreased interest
  • excoriation

Most common drug interactions by age *:

0-1:
  • feeding disorder neonatal
  • foetal exposure during pregnancy
  • low birth weight baby
  • premature baby
  • respiratory disorder neonatal
  • breech presentation
20-29:
  • rash
  • acne
  • cheilitis
  • chest pain
  • drug abuser
  • dry mouth
  • electrocardiogram qt prolonged
  • electrocardiogram st-t segment abnormal
  • electrocardiogram u-wave abnormality
30-39:
  • attention deficit/hyperactivity disorder
  • foetal exposure during pregnancy
  • hepatocellular injury
  • maternal drugs affecting foetus
  • restlessness
  • screaming
  • weight decreased
  • acute hepatic failure
  • hepatic encephalopathy
40-49:
  • anxiety
  • abdominal pain
  • animal bite
  • blood cholesterol increased
  • chest pain
  • constipation
  • decreased interest
  • excoriation
  • fatigue
  • general physical health deterioration
50-59:
  • drug dependence
  • fatigue
  • hypoaesthesia
  • nausea
  • overdose
  • pre-existing condition improved
  • road traffic accident
  • stress
  • substance abuse
  • drug abuse

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Suboxone and Clindamycin phosphate?

Interactions between Suboxone and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Clindamycin phosphate and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Clindamycin phosphate (clindamycin phosphate) is often used to treat acne. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Suboxone, Clindamycin phosphate

You may be interested in these reviews

More reviews for: Suboxone, Clindamycin phosphate